Found: 11
Select item for more details and to access through your institution.
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 1, doi. 10.1159/000517457
- Publication type:
- Article
Cabozantinib plus Nivolumab: Neuer RCC-Erstlinienstandard?
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 362, doi. 10.1159/000517347
- Publication type:
- Article
Luspatercept bei Niedrigrisiko-MDS: MEDALIST-Studie zeigt Mehrfachansprechen.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 360, doi. 10.1159/000517346
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 364, doi. 10.1159/000517321
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 368, doi. 10.1159/000517216
- Publication type:
- Article
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 301, doi. 10.1159/000516262
- By:
- Publication type:
- Article
Retrospective Analysis of the Clinical Presentation, Treatment and Outcome of Angiosarcoma in a Sarcoma Referral Center.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 322, doi. 10.1159/000516000
- By:
- Publication type:
- Article
Maintaining an Adult Hematology/Oncology Service at a Tertiary Care Center during the SARS-CoV-2 Pandemic: An Eight-Week-Experience with a Newly Implemented Procedural Plan.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 354, doi. 10.1159/000515828
- By:
- Publication type:
- Article
The Impact of Platinum-Containing Chemotherapies in Advanced Triple-Negative Breast Cancer: Meta-Analytical Approach to Evaluating Its Efficacy and Safety.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 333, doi. 10.1159/000515353
- By:
- Publication type:
- Article
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Adjuvant Setting for Patients with Resected Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: A Meta-Analysis with 11 Trials.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 344, doi. 10.1159/000515230
- By:
- Publication type:
- Article
The Poor Prognosis of Patients with Stage III Gastric Cancer after D2 Dissection Is Mainly due to Lymphatic Metastasis, Especially the Metastasis of No.12a LN: A Nested Case-Control Study.
- Published in:
- Oncology Research & Treatment, 2021, v. 44, n. 6, p. 313, doi. 10.1159/000512934
- By:
- Publication type:
- Article